Media & Events
Contact
Investors
About
+
-
Get To Know Us
Leadership Team
Board Of Directors
Commercial Team
A Welcoming CDMO: It's The Texas In Us
Careers
Clinical Biomanufacturing
+
-
Clinical Biomanufacturing
+
-
cGMP Mammalian Cell Culture
cGMP Microbial Fermentation
Process Development
+
-
Mammalian Cell Culture Development
Cell Therapy Development
Microbial Fermentation Development
Downstream Process Development
Formulation Development
Commercial Manufacturing
Bioanalytical Services
+
-
Methods Development
Technologies
Pre-Clinical & Product Development Services
+
-
Toxicokinetic Studies (TK)
Comprehensive Immune Profiling
Cell-Based Potency Assays
CMC Analytical Support Services
+
-
Release Testing
Stability Testing
Bioassays
Media & Events
Contact
Investors
Latest From Scorpius
All Media
News
Events
Articles
Blogs
Resources
articles
Scorpius' Ania Szymanska Featured in Pharmaceutical Technology’s February 2024 E-book
Scorpius BioManufacturing's Site Head of Quality, Ania Szymanska shares her expertise on how to evaluate a CDMO’s commitment to quality in Pharmaceutical Technology’s February 2024 E-book.
March 4, 2024
articles
Why Fina Biosolutions Partnered With Scorpius BioManufacturing for cGMP Production of EcoCRM® (CRM197)
Why Fina Biosolutions Partnered With Scorpius BioManufacturing for cGMP Production of EcoCRM® (CRM197)
December 8, 2023
articles
From frustration to innovation: a CDMO’s mission to empower emerging biotechs
Capacity, capacity, capacity. This seems to be all the industry talks about. A global pandemic magnified the need for more biologics manufacturing capacity. Capacity, however, isn’t the whole story.
October 20, 2023
articles
Does Your Biologics CDMO Truly Have a Culture of Quality?
Joe Payne, Scorpius' President & COO, shares what 20+ years in pharma has taught him about creating a culture of quality.
July 27, 2023
articles
Biologics Outsourcing: Decision Drivers and Key Considerations
A recent survey of 100 decision makers at innovative biologics companies revealed 57% of respondents believe their companies’ outsourcing activities will increase over the next two years, while a furt...
April 17, 2023
articles
An Experienced CDMO Can Be a Differentiator in the Rapidly Growing Biologics Market
By providing end-to-end services — including secure supply chains — CRO/CDMOs, like Scorpius BioManufacturing can help biologics developers meet accelerated timelines and establish a real competitive ...
January 31, 2023
articles
The Bioanalytical Development Journey
Biopharma companies outsource pharmaceutical development and manufacturing from discovery, bioanalytical testing, qualification to validation.
May 18, 2022
articles
Evaluating Single-Use Technologies for Biomanufacturing
Single-use technologies (SUTs) are ideal for multiproduct facilities producing smaller volumes of materials.
November 22, 2021
articles
ABC: Analytics for Biomanufacturing and Clinical Trials of Biomanufactured Products
Samir Lakhashe, Director, Bioanalysis, discusses assay categorization, the company's growing toolbox, predictions for the future, and what scientists who want to join the growing team should know, wit...
October 15, 2021